A phase I trial of weekly topotecan and carboplatin in potentially platinum sensitive ovarian and peritoneal carcinoma.

被引：0
|
作者：
Smrekar, M
Buller, RE
Haba, P
Visser, C
Rose, PG
机构：
[1] Hillcrest Hosp, Mayfield Hts, OH USA
[2] GlaxoSmithKline, Philadelphia, PA USA
[3] Metrohlth Med Ctr, Cleveland, OH USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2004年 / 22卷 / 14期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5147
引用
收藏
页码：485S / 485S
页数：1
相关论文
共 50 条
  • [1] A phase I/II trial of weekly topotecan and carboplatin in potentially platinum-sensitive relapsed ovarian and peritoneal carcinoma
    Rose, PG
    Smrekar, M
    Haba, P
    Visser, C
    Beeler, JF
    GYNECOLOGIC ONCOLOGY, 2005, 99 (03) : 714 - 719
  • [2] A phase II trial of weekly paclitaxel and every 3 weeks of carboplatin in potentially platinum-sensitive ovarian and peritoneal carcinoma
    Rose, PG
    Smrekar, M
    Fusco, N
    GYNECOLOGIC ONCOLOGY, 2005, 96 (02) : 296 - 300
  • [3] A preliminary report of a phase II study of weekly topotecan in platinum-sensitive recurrent ovarian and peritoneal carcinoma
    Rodriguez, M
    Method, MW
    Lewandowski, G
    Vaccarello, L
    Ansari, RH
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 464S - 464S
  • [4] PHASE II TRIAL OF LAPATINIB IN COMBINATION WITH WEEKLY TOPOTECAN IN PATIENTS WITH PLATINUM-REFRACTORY/RESISTANT OVARIAN AND PRIMARY PERITONEAL CARCINOMA
    Haluska, P.
    Oberg, A. L.
    Dakhil, S. R.
    Ziegler, K. L. Allen
    Rowland, K. M.
    Hartmann, L. C.
    Moore, D. F.
    Keeney, G. L.
    Peethambaram, P. P.
    ANNALS OF ONCOLOGY, 2009, 20 : 43 - 43
  • [5] Topotecan weekly bolus chemotherapy for relapsed platinum-sensitive ovarian and peritoneal cancers
    Morris, Robert
    Alvarez, Ronald D.
    Andrews, Stephen
    Malone, John
    Bryant, Christopher
    Heilbrun, Lance K.
    Smith, Daryn
    Schmip, Veronica
    Munkarah, Adnan
    GYNECOLOGIC ONCOLOGY, 2008, 109 (03) : 346 - 352
  • [6] Phase II study of weekly topotecan in patients with relapsed platinum-sensitive ovarian or peritoneal cancer.
    Morris, RT
    Alvarez, RD
    Malone, J
    Bryant, C
    Andrews, SJ
    Kilgore, L
    Phibbs, GD
    Heilbrun, L
    Munkarah, AR
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 468S - 468S
  • [7] Phase II trial of combination topotecan and carboplatin chemotherapy in platinum-sensitive ovarian cancer.
    Shahin, MS
    Hanjani, P
    Nolte, S
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 485S - 485S
  • [8] Weekly topotecan in patients with platinum-sensitive and platinum-resistant recurrent ovarian and peritoneal cancers.
    Tummala, M. K.
    Alagarsamy, S.
    Chyou, P.
    McGuire, W. P., III
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [9] Phase II trial of docetaxel and carboplatin in recurrent platinum-sensitive ovarian, peritoneal and tubal cancer
    Strauss, H. G.
    Henze, A.
    Teichmann, A.
    Karbe, I.
    Baumgart, A.
    Thomssen, C.
    Koelbl, H.
    GYNECOLOGIC ONCOLOGY, 2007, 104 (03) : 612 - 616
  • [10] Weekly docetaxel and carboplatin for recurrent ovarian and peritoneal cancer: A phase II trial
    Kushner, David M.
    Connor, Joseph P.
    Sanchez, Federico
    Volk, Michael
    Schink, Julian C.
    Bailey, Howard H.
    Harris, Linda S.
    Stewart, Sarah L.
    Fine, Jason
    Hartenbach, Ellen M.
    GYNECOLOGIC ONCOLOGY, 2007, 105 (02) : 358 - 364
12345